Using Nvidia and GE Healthcare technology, the robotic surgery system is intended to help doctors detect lung cancer earlier.

J&J acquired Monarch in its $3.4 billion acquisition of Auris Health in 2019. In November, J&J received an investigational device exemption to start a U.S. clinical trial for its Ottava soft ...

Correction: An earlier version of this story incorrectly said the company’s FDA approval applied to Monarch Quest’s robotic platform.